San Francisco Bay Area biotech stories.
Wednesday, September 26, 2012
McKesson names Mark Walchirk president of U.S. pharmaceutical unit
McKesson Corp. named Mark Walchirk as president of its U.S. pharmaceutical unit, its largest business, effective immediately
. He will be the unit's third president in the last 21 months. Walchirk, most recently COO of McKesson Specialty Health, has been with the San Francisco-based pharmaceutical distribution and health care information technology giant (NYSE: MCK) for 11 years. He succeeds
who was named executive vice president of corporate strategy and business development
of McKesson Corp. in late August.
Share to Twitter
Share to Facebook
Share to Pinterest
Post a Comment
Post Comments (Atom)